| Literature DB >> 29931266 |
Gavin Boerboom1, Theo van Kempen1,2, Alberto Navarro-Villa1, Adriano Pérez-Bonilla1.
Abstract
White striping (WS) is a major problem affecting the broiler industry. Fillets affected by this myopathy present pathologies that compromise the quality of the meat, and most importantly, make the fillets more prone to rejection by the consumer. The exact etiology is still unknown, which is why a metabolomics analysis was performed on breast samples of broilers. The overall objective was to identify biological pathways involved in the pathogenesis of WS. The analysis was performed on a total of 51 muscle samples and distinction was made between normal (n = 19), moderately affected (n = 24) and severely affected (n = 8) breast fillets. Samples were analyzed using gas chromatographic mass spectral analysis and liquid chromatography quadrupole time-of-flight mass spectrometry. Data were subsequently standardized, normalized and analyzed using various multivariate statistical procedures. Metabolomics allowed for the identification of several pathways that were altered in white striped breast fillets. The tricarboxylic acid cycle exhibited opposing directionalities. This is described in literature as the backflux and enables the TCA cycle to produce high-energy phosphates through matrix-level phosphorylation and, therefore, produce energy under conditions of hypoxia. Mitochondrial fatty acid oxidation was limited due to disturbances in especially cis-5-14:1 carnitine (log2 FC of 2, P < 0.01). Because of this, accumulation of harmful fatty acids took place, especially long-chain ones, which damages cell structures. Conversion of arginine to citrulline increased presumably to produce nitric oxide, which enhances blood flow under conditions of hypoxia. Nitric oxide however also increases oxidative damage. Increases in taurine (log2 FC of 1.2, P < 0.05) suggests stabilization of the sarcolemma under hypoxic conditions. Lastly, organic osmolytes (sorbitol, taurine, and alanine) increased (P < 0.05) in severely affected birds; likely this disrupts cell volume maintenance. Based on the results of this study, hypoxia was the most likely cause/initiator of WS in broilers. We speculate that birds suffering from WS have a vascular support system in muscle that is borderline adequate to support growth, but triggers like activity results in local hypoxia that damages tissue.Entities:
Mesh:
Year: 2018 PMID: 29931266 PMCID: PMC6162359 DOI: 10.3382/ps/pey266
Source DB: PubMed Journal: Poult Sci ISSN: 0032-5791 Impact factor: 3.352
Figure 1.The largest significant fold changes in fats present between severe white striping and no white striping. Longer fatty acids are increased substantially in the severely affected birds.
Figure 2.Significant fold changes in carnitine esters between normal and severe WS. Carnitine esters involved in the transport of long-chain fatty acids into the mitochondria are all lowered, while C14:1 carnitine is increased (serves as a marker for beta-oxidation defects).
Largest fold changes between the moderate-normal and severe-normal using ANOVA, showing the top four and bottom four largest significant changes in metabolite concentrations.
| Moderate vs normal | Severe-Normal | ||
|---|---|---|---|
| Compound | Fold Change [log2] | Compound | Fold Change [log2] |
| 2,3-bis(acetyloxy)propyl icosanoate | 5.6 | 2,3-bis(acetyloxy)propyl icosanoate | 6.4 |
| (5-D-ribonyl)hopane | 5.4 | (5-D-ribonyl)hopane | 6.1 |
| Delta 8,14 -Sterol | 4.6 | Delta 8,14 -Sterol | 5.5 |
| Vitamin K1 2,3-epoxide | 4.4 | Sorbitan palmitate | 5.3 |
| Asp-Glu-Glu-Gly | −1.6 | Maltose | −1.7 |
| Lys-Pro-Pro | −1.7 | Spermine | −1.7 |
| (S)-[8]-Gingerol | −1.7 | Ala-Lys-Thr-Arg | −1.8 |
| Ala-Glu-Asp-Ile | −1.8 | Stearoylcarnitine | −3.4 |
Pathway analysis results (normal-severe) using Metaboanalyst. The P-value was calculated from pathway enrichment analysis and the impact was calculated using pathway topological analysis using betweenness centrality.
|
| Impact | |
|---|---|---|
| Glyoxylate and dicarboxylate metabolism | <0.01 | 0.29 |
| Galactose metabolism | <0.01 | 0.07 |
| Taurine and hypotaurine metabolism | <0.01 | 0.50 |
| Citrate cycle (TCA cycle) | <0.01 | 0.31 |
| Arginine and proline metabolism | 0.01 | 0.54 |
| Tyrosine metabolism | 0.03 | 0.13 |
| Starch and sucrose metabolism | 0.03 | 0.12 |
| Purine metabolism | 0.03 | 0.04 |
| Fructose and mannose metabolism | 0.03 | 0.19 |
| Butanoate metabolism | 0.03 | 0.13 |
Figure 3.TCA cycle depicting changes between severe WS and non-affected birds. Metabolites that were not present in the dataset do not have numbers. Dashed arrows show the direction of change that occurs in white striped affected broilers.
Figure 4.Effect of moderate or severe WS on tissue mineral level. Ratios are in relation to the normal group. * indicates significance (P <0.05).
Figure 5.Conversion of arginine to citrulline. Numbers below metabolites depict fold change (log2) and p-value (FDR-adjusted).
Table of significantly affected metabolites based on ANOVA between the groups (FDR corrected P < 0.05).
| Metabolite |
| FDR |
|---|---|---|
| cis-5-Tetradecenoylcarnitine |
| Q < 0.001 |
| MG1829Z.12Z/00/00 |
| Q < 0.001 |
| N-Acetyl-2,6-diethylaniline |
| Q < 0.001 |
| 2,3-bisAcetyloxypropyl icosanoate |
| Q < 0.001 |
| Lys-Lys-Lys-Val |
| Q < 0.001 |
| Theonellasterol B |
| Q < 0.001 |
| Stearoylcarnitine |
| Q < 0.001 |
| PI403 |
| Q < 0.001 |
| Citric acid |
| Q < 0.001 |
| Sorbitan palmitate |
| Q < 0.01 |
| 16-Hydroxy hexadecanoic acid |
| Q < 0.01 |
| PR 5-D-ribonylhopane |
| Q < 0.01 |
| Norselic acid C |
| Q < 0.01 |
| Vitamin K1 2,3-epoxide |
| Q < 0.01 |
| 2',3'-Dihydro-phytomenadione |
| Q < 0.01 |
| Ala-Asn-Pro-Pro |
| Q < 0.01 |
| Lethedoside B |
| Q < 0.01 |
| ST dimethyl60/60/60/30 5Z.7E.22E.24E.24bE-1S.3R-26.27-dimethyl-24a.24b.24c-trihomo-9.10-seco-5.7.1019.22.24.24b-cholestahexaene-1.3.25-triol |
| Q < 0.01 |
| PI426 |
| Q < 0.01 |
| Delta 8,14 -Sterol |
| Q < 0.01 |
| Ergosterol |
| Q < 0.01 |
| Methyl-delta-ionone |
| Q < 0.01 |
| 2,3-Diacetoxypropyl stearate |
| Q < 0.01 |
| Asp-Leu-Pro-Ser |
| Q < 0.01 |
| Cys-Thr-Cys-His |
| Q < 0.01 |
| Alpha-Tocotrienol |
| Q < 0.01 |
| PR Coenzyme Q8 |
| Q < 0.01 |
| Cys-Lys-Gln-Pro |
| Q < 0.01 |
| Cys-Leu-Cys-Cys |
| Q < 0.01 |
| Lys-Pro-Pro |
| Q < 0.01 |
| Ophrysanin |
| Q < 0.01 |
| Cyanidin |
| Q < 0.01 |
| Taurine |
| Q < 0.01 |
| MG1846Z.9Z.12Z.15Z/00/00 |
| Q < 0.01 |
| SMd423 |
| Q < 0.01 |
| Histamine |
| Q < 0.01 |
| 3-Methylbutyl dodecanoate |
| Q < 0.01 |
| 3-Methylbutyl decanoate |
| Q < 0.01 |
| 3-octaprenyl-4-hydroxy-5-methoxybenzoate |
| Q < 0.01 |
| Sorbitol |
| Q < 0.05 |
| 3-heptaprenyl-4-hydroxybenzoate |
| Q < 0.05 |
| L-thiazolidine-4-carboxylate |
| Q < 0.05 |
| Elaidic carnitine |
| Q < 0.05 |
| L-Malic acid |
| Q < 0.05 |
| Fructose |
| Q < 0.05 |
| Asp-Met-Cys-His |
| Q < 0.05 |
| Hydroxyprolyl-Histidine |
| Q < 0.05 |
| PI351 |
| Q < 0.05 |
| PS404 |
| Q < 0.05 |
| L-Methionine |
| Q < 0.05 |
| PS1819Z/180 |
| Q < 0.05 |
| 1-Phospho-alpha-D-galacturonate |
| Q < 0.05 |
| Thiomorpholine 3-carboxylate |
| Q < 0.05 |
| Quinic acid |
| Q < 0.05 |
| PEP-1819Z/1836Z.9Z.12Z |
| Q < 0.05 |
| alpha-Narcotine |
| Q < 0.05 |
| L-Palmitoylcarnitine |
| Q < 0.05 |
| Sinapinic acid-O-sulphate |
| Q < 0.05 |
| 2-Hydroxy-24-keto-octacosanolide |
| Q < 0.05 |
| Dimethylglycine |
| Q < 0.05 |
| Isoleucine |
| Q < 0.05 |
| Acetoacetic acid |
| Q < 0.05 |
| Artobiloxanthone |
| Q < 0.05 |